Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria

Author:

Zaloumis S G1,Tarning J2,Krishna S3,Price R N4,White N J25,Davis T M E6,McCaw J M1,Olliaro P57,Maude R J28,Kremsner P910,Dondorp A511,Gomes M7,Barnes K12,Simpson J A1

Affiliation:

1. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global HealthUniversity of Melbourne Melbourne Australia

2. Mahidol‐Oxford Tropical Medicine Research Unit, Faculty of Tropical MedicineMahidol University Bangkok Thailand

3. Institute for Infection and Immunity, St. George'sUniversity of London London UK

4. Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of MedicineUniversity of Oxford Oxford UK

5. Centre for Tropical Medicine, Nuffield Department of Clinical MedicineUniversity of Oxford Oxford UK

6. School of Medicine and Pharmacology, Fremantle HospitalUniversity of Western Australia Fremantle Australia

7. World Health Organization Genève Switzerland

8. Centre for Tropical Medicine, Nuffield Department of MedicineUniversity of Oxford Oxford UK

9. Medical Research UnitAlbert Schweitzer Hospital Lambaréné Gabon

10. Institute for Tropical Medicine, Department of ParasitologyUniversity of Tübingen Tübingen Germany

11. Faculty of Tropical MedicineMahidol University Bangkok Thailand

12. Division of Clinical Pharmacology, Department of MedicineUniversity of Cape Town Cape Town South Africa

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Evidence Based Optimal Dosing of Intravenous Artesunate in Children with Severe Falciparum Malaria;Clinical Pharmacology & Therapeutics;2023-09-15

2. Antimalarial treatment in infants;Expert Opinion on Pharmacotherapy;2022-10-05

3. Pediatric Malaria;Pediatric Clinics of North America;2022-02

4. Reply to White et al;Clinical Infectious Diseases;2022-01-12

5. Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA);Clinical Infectious Diseases;2022-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3